[图书][B] Pharmacology Research And Textbook 2: HIV-1 Integrase Inhibitors, Coenzyme Q10, and Ferroptosis

AT Mohammadi, R Nouralizadeh, N Naghsh, S Abbasi… - books.google.com
Page 1 Pharmacology Research And Textbook 2 Chapter1: HIV-1 Integrase Inhibitors and
Neurodevelopment Chapter2: Coenzyme Q10 Chapter3: Ferroptosis Author in Chief …

HIV‐1 integrase inhibitors: 2005–2006 update

R Dayam, R Gundla, LQ Al‐Mawsawi… - Medicinal Research …, 2008 - Wiley Online Library
Abstract HIV‐1 integrase (IN) catalyzes the integration of proviral DNA into the host genome,
an essential step for viral replication. Inhibition of IN catalytic activity provides an attractive …

HIV-1 integrase inhibitors: a decade of research and two drugs in clinical trial

AA Johnson, C Marchand… - Current Topics in …, 2004 - ingentaconnect.com
AIDS is currently treated with a combination therapy of reverse transcriptase and protease
inhibitors. Recently, the FDA approved a drug targeting HIV-1 entry into cells. There are …

Novel integrase inhibitors for HIV

N Prada, M Markowitz - Expert Opinion on Investigational Drugs, 2010 - Taylor & Francis
Importance of the field: Integrase inhibitors are the newest class of antiretroviral agents
developed to treat HIV-1 infection. Raltegravir (RAL), the only integrase inhibitor (INI) …

HIV-1 integrase inhibitors: an emerging clinical reality

R Dayam, LQ Al-Mawsawi, N Neamati - Drugs in R & D, 2007 - Springer
From the discovery of HIV-1 integrase (IN) inhibitors using enzyme-based assays in 1992, it
has taken 15 years to achieve success in human clinical trials. Currently available …

A historical sketch of the discovery and development of HIV-1 integrase inhibitors

A Savarino - Expert opinion on investigational drugs, 2006 - Taylor & Francis
The long process of HIV-1 integrase inhibitor discovery and development can be attributed
to both the complexity of HIV-1 integration and poor 'integration'of these researches into …

Targeting HIV-1 integrase.

K Sayasith, G Sauvé, J Yelle - Expert opinion on therapeutic targets, 2001 - europepmc.org
Human immunodeficiency virus Type 1 (HIV-1) integrase is an essential enzyme for the
obligatory integration of the viral DNA into the infected cell chromosome. As no cellular …

[HTML][HTML] HIV integrase inhibitors—out of the pipeline and into the clinic

DV Havlir - New England Journal of Medicine, 2008 - Mass Medical Soc
Human immunodeficiency virus (HIV) infection has been transformed over the past two
decades from a fatal to a chronic disease, because of combination antiretroviral therapy—a …

HIV-1 integrase: from biology to chemotherapeutics

E Zeinalipour-Loizidou, C Nicolaou… - Current HIV …, 2007 - ingentaconnect.com
AIDS has claimed the lives of 25 million people worldwide, an additional 40 million people
are HIV-infected and new cases are being diagnosed every year. Despite the fact that …

New developments in diketo-containing inhibitors of HIV-1 integrase

G Zhao, C Wang, C Liu, H Lou - Mini Reviews in Medicinal …, 2007 - ingentaconnect.com
HIV-1 integrase is one of the three enzymes, which are critical for viral replication. It
catalyzes the integration of the HIV genome into the cellular chromosome. Since there is no …